Penserra Capital Management LLC Akero Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$19.87 - $26.24 $15,896 - $20,992	-800 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$18.65 - $25.46 $93 - $127	5 Added 0.63%	800 $17,000
Q2 2021 Aug 12, 2021	BUY	$24.81 - $32.35 $124 - $161	5 Added 0.63%	795 $19,000
Q1 2021 May 13, 2021	SELL	$24.04 - $34.19 $120 - $170	-5 Reduced 0.63%	790 $22,000
Q4 2020 Feb 12, 2021	BUY	$25.12 - $29.89 $12,484 - $14,855	497 Added 166.78%	795 $20,000
Q3 2020 Nov 13, 2020	BUY	$30.79 - $39.92 $9,175 - $11,896	298 New	298 $9,000

190

73.8M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.52B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.